Uniunea Europeană - română - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetul zaharat, tip 2 - medicamente utilizate în diabet - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 și 5. 1 pentru datele disponibile pe diferite combinații).

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

combino pharm (malta) ltd. - malta - vildagliptinum - compr. - 50mg - antidiabetice orale inhibitori ai dipeptidil peptidazei 4 (dpp-4)

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

combino pharm (malta) ltd. - malta - vildagliptinum - compr. - 50mg - antidiabetice orale inhibitori ai dipeptidil peptidazei 4 (dpp-4)

Uniunea Europeană - română - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, clorhidrat de metformină - diabetul zaharat, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 și 5. 1 pentru datele disponibile pe diferite combinații).

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

gedeon richter romania s.a. - romania - combinatii (vildagliptinum+metforminum) - compr. film. - 50mg/1000mg - analogi ai glp-1 combinatii de antidiabetice orale

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

gedeon richter romania s.a. - romania - combinatii (vildagliptinum+metforminum) - compr. film. - 50mg/850mg - analogi ai glp-1 combinatii de antidiabetice orale

Uniunea Europeană - română - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetul zaharat, tip 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 și 5. 1 pentru datele disponibile pe diferite combinații).

Uniunea Europeană - română - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetul zaharat, tip 2 - medicamente utilizate în diabet - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 și 5. 1 pentru datele disponibile pe diferite combinații).

Uniunea Europeană - română - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetul zaharat, tip 2 - medicamente utilizate în diabet - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Uniunea Europeană - română - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, clorhidrat de metformină - diabetul zaharat, tip 2 - medicamente utilizate în diabet - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.